Annual EBITDA:
-$80.61M-$32.02M(-65.88%)Summary
- As of today, ZVRA annual EBITDA is -$80.61 million, with the most recent change of -$32.02 million (-65.88%) on December 31, 2024.
- During the last 3 years, ZVRA annual EBITDA has fallen by -$88.60 million (-1109.44%).
- ZVRA annual EBITDA is now -1109.44% below its all-time high of $7.99 million, reached on December 31, 2021.
Performance
ZVRA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$10.68M-$6.96M(-187.58%)Summary
- As of today, ZVRA quarterly EBITDA is -$10.68 million, with the most recent change of -$6.96 million (-187.58%) on June 30, 2025.
- Over the past year, ZVRA quarterly EBITDA has increased by +$11.55 million (+51.97%).
- ZVRA quarterly EBITDA is now -252.02% below its all-time high of $7.02 million, reached on March 1, 2021.
Performance
ZVRA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$53.85M+$11.55M(+17.67%)Summary
- As of today, ZVRA TTM EBITDA is -$53.85 million, with the most recent change of +$11.55 million (+17.67%) on June 30, 2025.
- Over the past year, ZVRA TTM EBITDA has increased by +$16.50 million (+23.45%).
- ZVRA TTM EBITDA is now -724.32% below its all-time high of $8.63 million, reached on June 1, 2021.
Performance
ZVRA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ZVRA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -65.9% | +52.0% | +23.4% |
| 3Y3 Years | -1109.4% | -54.2% | -294.4% |
| 5Y5 Years | -302.4% | -501.3% | -725.5% |
ZVRA EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -1109.4% | at low | -187.6% | +58.4% | -203.8% | +33.3% |
| 5Y | 5-Year | -1109.4% | at low | -252.0% | +58.4% | -724.3% | +33.3% |
| All-Time | All-Time | -1109.4% | at low | -252.0% | +58.4% | -724.3% | +33.3% |
ZVRA EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$10.68M(-187.6%) | -$53.85M(+17.7%) |
| Mar 2025 | - | -$3.71M(+73.0%) | -$65.40M(+18.9%) |
| Dec 2024 | -$80.61M(-65.9%) | -$13.77M(+46.4%) | -$80.61M(+0.1%) |
| Sep 2024 | - | -$25.69M(-15.5%) | -$80.73M(-14.8%) |
| Jun 2024 | - | -$22.23M(-17.5%) | -$70.34M(-29.6%) |
| Mar 2024 | - | -$18.92M(-36.3%) | -$54.28M(-12.8%) |
| Dec 2023 | -$48.60M(-102.8%) | -$13.88M(+9.3%) | -$48.11M(-11.3%) |
| Sep 2023 | - | -$15.30M(-147.8%) | -$43.24M(-26.6%) |
| Jun 2023 | - | -$6.17M(+51.6%) | -$34.17M(+2.1%) |
| Mar 2023 | - | -$12.75M(-41.5%) | -$34.92M(-45.7%) |
| Dec 2022 | -$23.96M(-400.0%) | -$9.01M(-44.7%) | -$23.96M(-35.2%) |
| Sep 2022 | - | -$6.23M(+10.0%) | -$17.72M(-29.8%) |
| Jun 2022 | - | -$6.92M(-285.9%) | -$13.65M(-1540.9%) |
| Mar 2022 | - | -$1.79M(+35.4%) | -$832.00K(-110.4%) |
| Dec 2021 | $7.99M(+277.2%) | - | - |
| Dec 2021 | - | -$2.78M(-28.8%) | $7.99M(+4.9%) |
| Sep 2021 | - | -$2.16M(-136.6%) | $7.61M(-11.7%) |
| Jun 2021 | - | $5.90M(-16.0%) | $8.63M(+60.0%) |
| Mar 2021 | - | $7.02M(+323.0%) | $5.39M(+201.0%) |
| Dec 2020 | -$4.51M(+77.5%) | -$3.15M(-174.9%) | -$5.34M(+18.2%) |
| Sep 2020 | - | -$1.15M(-143.1%) | -$6.52M(-215.6%) |
| Jun 2020 | - | $2.66M(+171.9%) | -$2.07M(+83.4%) |
| Mar 2020 | - | -$3.70M(+14.6%) | -$12.45M(+37.9%) |
| Dec 2019 | -$20.03M | -$4.33M(-231.0%) | -$20.03M(+19.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $3.31M(+142.9%) | -$24.89M(+44.0%) |
| Jun 2019 | - | -$7.72M(+31.7%) | -$44.44M(+12.1%) |
| Mar 2019 | - | -$11.29M(-22.9%) | -$50.55M(+6.3%) |
| Dec 2018 | -$53.94M(-63.3%) | -$9.19M(+43.4%) | -$53.94M(-2.1%) |
| Sep 2018 | - | -$16.24M(-17.5%) | -$52.82M(-14.6%) |
| Jun 2018 | - | -$13.82M(+5.9%) | -$46.10M(-14.1%) |
| Mar 2018 | - | -$14.69M(-82.1%) | -$40.42M(-22.4%) |
| Dec 2017 | -$33.03M(+3.7%) | -$8.06M(+15.3%) | -$33.03M(+7.6%) |
| Sep 2017 | - | -$9.53M(-17.0%) | -$35.74M(-6.5%) |
| Jun 2017 | - | -$8.14M(-11.5%) | -$33.56M(+3.2%) |
| Mar 2017 | - | -$7.30M(+32.2%) | -$34.67M(-1.0%) |
| Dec 2016 | -$34.30M(-50.9%) | -$10.77M(-46.6%) | -$34.31M(-11.4%) |
| Sep 2016 | - | -$7.35M(+20.5%) | -$30.80M(-3.0%) |
| Jun 2016 | - | -$9.25M(-33.2%) | -$29.91M(-12.4%) |
| Mar 2016 | - | -$6.94M(+4.3%) | -$26.60M(-17.0%) |
| Dec 2015 | -$22.73M(-38.9%) | -$7.26M(-12.4%) | -$22.73M(+0.9%) |
| Sep 2015 | - | -$6.46M(-8.8%) | -$22.94M(+0.2%) |
| Jun 2015 | - | -$5.94M(-93.0%) | -$22.99M(-16.4%) |
| Mar 2015 | - | -$3.08M(+58.8%) | -$19.75M(-6.9%) |
| Dec 2014 | -$16.37M(-252.0%) | -$7.47M(-14.8%) | -$18.47M(-67.9%) |
| Sep 2014 | - | -$6.51M(-141.4%) | -$11.00M(-144.9%) |
| Jun 2014 | - | -$2.70M(-50.2%) | -$4.49M(-150.2%) |
| Mar 2014 | - | -$1.79M | -$1.79M |
| Dec 2013 | -$4.65M(+4.5%) | - | - |
| Dec 2012 | -$4.87M | - | - |
FAQ
- What is Zevra Therapeutics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Zevra Therapeutics, Inc.?
- What is Zevra Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Zevra Therapeutics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Zevra Therapeutics, Inc.?
- What is Zevra Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Zevra Therapeutics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Zevra Therapeutics, Inc.?
- What is Zevra Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Zevra Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of ZVRA is -$80.61M
What is the all-time high annual EBITDA for Zevra Therapeutics, Inc.?
Zevra Therapeutics, Inc. all-time high annual EBITDA is $7.99M
What is Zevra Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, ZVRA annual EBITDA has changed by -$32.02M (-65.88%)
What is Zevra Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of ZVRA is -$10.68M
What is the all-time high quarterly EBITDA for Zevra Therapeutics, Inc.?
Zevra Therapeutics, Inc. all-time high quarterly EBITDA is $7.02M
What is Zevra Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, ZVRA quarterly EBITDA has changed by +$11.55M (+51.97%)
What is Zevra Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of ZVRA is -$53.85M
What is the all-time high TTM EBITDA for Zevra Therapeutics, Inc.?
Zevra Therapeutics, Inc. all-time high TTM EBITDA is $8.63M
What is Zevra Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, ZVRA TTM EBITDA has changed by +$16.50M (+23.45%)